Where can I buy Xenon Pharmaceuticals stock?
Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Xenon Pharmaceuticals' stock price today? One share of XENE stock can currently be purchased for approximately $28.98.
How many shares of Xenon Pharmaceuticals does pimstone still own?
The total transaction amounted to $550,061. Pimstone still owns a total of 210,186 shares of Xenon Pharmaceuticals worth, $6,568,312. Xenon Pharmaceuticals shares are trading down 2.31%
What is Xenon Pharmaceuticals's PE (price/earnings) ratio?
The P/E ratio of Xenon Pharmaceuticals is -15.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Xenon Pharmaceuticals has a P/B Ratio of 6.21.
What is xenon (Xen)?
XEN is a utility token that can be used on the platform provided by Xenon for purchasing and sponsoring music. The goal is to increase profits for music producers by bypassing intermediaries in the existing distribution process.
What is Xenon Pharmaceuticals?
Does market cap include convertible securities?
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.
How much does Xenon Pharmaceuticals make?
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
What is Xenon Pharmaceuticals?
How much money does Xenon Pharmaceuticals make? Xenon Pharmaceuticals has a market capitalization of $749.75 million and generates $32.17 million in revenue each year. The biopharmaceutical company earns $-28,840,000.00 in net income (profit) each year or ($0.81) on an earnings per share basis.
What is the Xenon symbol?
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
Where is Xenon Pharmaceuticals located?
Xenon Pharmaceuticals trades on the NASDAQ under the ticker symbol "XENE."
Does Xenon Pharmaceuticals pay dividends?
Xenon Pharmaceuticals' mailing address is 200 - 3650 GILMORE WAY, BURNABY A1, V5G 48W. The biopharmaceutical company can be reached via phone at (604) 484-3300, via email at [email protected], or via fax at 604-484-3450.
Market data is untracked
Xenon Pharmaceuticals does not currently pay a dividend.
XEN Price Live Data
Change the wallet network in the MetaMask Application to add this contract.
